Illustrates data on substance use treatment in Prince Edward Island in 2016–2017.
Featuring Dr. Hakique Virani, Public Health and Addiction Medicine Specialist, as this year’s Keynote Speaker.
Summarizes four important facts currently known about COVID-19 and how it can affect people who smoke or vape cannabis products.
Presents substance use trends and describes whether expected substance use aligned with actual substance contents. Data were collected from harm reduction sites in seven regions across Canada that participated in the Community Urinalysis and Self…
Summarizes research on the use of MDMA (street named ecstasy or molly), a synthetically derived chemical used recreationally. Less than 1% of Canadian aged 15 and older reported past-year use of ecstasy and 1 in 25 youth in grades 10–12 reported…
Facilitates conversations and increases awareness of the stigma that surrounds people who use substances, their support networks and service providers in the community. Developed in partnership with the Community Addictions Peer Support…
Highlights impacts from CCSA’s Stigma Ends with Me activities, including workshops, release of a stigma primer and other campaigns.
Presents opioid and fentanyl use trends and describes whether expected substance use aligned with actual substance contents.
This publication has been archived on the CCSA website and was current when it was published. It is available for reference or research purposes.
Provides a list of the reports by the Canadian Community Epidemiology Network on Drug Use (…
Case study outlines the Thunder Bay Drug Strategy and Community Safety and Well-Being Thunder Bay’s Brain Builders Lab project.
Case study summarizes the Open Doors for Lanark Children and Youth (Open Doors)’s Brain Builders Lab project.
Intended to accompany the Community Urinalysis and Self-Report Project: Cross-Canada Report on the Use of Drugs from the Unregulated Supply, 2021-2023 Data series.
